Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies

Mickael Hiligsmann; Daniel Pinto; Elaine Dennison; Nasser Al-Daghri; Charlotte Beaudart; Jaime Branco; Olivier Bruyère; Philip G. Conaghan; Cyrus Cooper; Gabriel Herrero-Beaumont; Famida Jiwa; Willem Lems; Rene Rizzoli; Thierry Thomas; Nicola Veronese; Jean Yves Reginster

doi:10.1007/s40520-018-1098-3

Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies

Mickael Hiligsmann, Daniel Pinto, Elaine Dennison, Nasser Al-Daghri, Charlotte Beaudart, Jaime Branco, Olivier Bruyère, Philip G. Conaghan, Cyrus Cooper, Gabriel Herrero-Beaumont, Famida Jiwa, Willem Lems, Rene Rizzoli, Thierry Thomas, Nicola Veronese, Jean Yves Reginster

Résultats de recherche: Contribution à un journal/une revue › Editorial › Revue par des pairs

16 Téléchargements (Pure)

langue originale	Anglais
journal	Aging Clinical and Experimental Research
Volume	31
Numéro de publication	1
Les DOIs	https://doi.org/10.1007/s40520-018-1098-3
Etat de la publication	Publié - 25 janv. 2019
Modification externe	Oui

Accès au document

10.1007/s40520-018-1098-3

s40520-018-1098-3Version finale publiée, 535 KB

Autres fichiers et liens

Lien vers la publication sur Scopus

Contient cette citation

Hiligsmann, M., Pinto, D., Dennison, E., Al-Daghri, N., Beaudart, C., Branco, J., Bruyère, O., Conaghan, P. G., Cooper, C., Herrero-Beaumont, G., Jiwa, F., Lems, W., Rizzoli, R., Thomas, T., Veronese, N., & Reginster, J. Y. (2019). Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies. Aging Clinical and Experimental Research, 31(1). https://doi.org/10.1007/s40520-018-1098-3

@article{952ce0078e134eac9abfeeb18fb16999,

title = "Patients{\textquoteright} preferences for osteoarthritis treatment: the value of stated-preference studies",

author = "Mickael Hiligsmann and Daniel Pinto and Elaine Dennison and Nasser Al-Daghri and Charlotte Beaudart and Jaime Branco and Olivier Bruy{\`e}re and Conaghan, {Philip G.} and Cyrus Cooper and Gabriel Herrero-Beaumont and Famida Jiwa and Willem Lems and Rene Rizzoli and Thierry Thomas and Nicola Veronese and Reginster, {Jean Yves}",

note = "Funding Information: No funding was received for this study. The authors are grateful to the Prince Mutaib Chair for Biomarkers of Osteoporosis, King Saud University, Riyadh, Saudi Arabia, for its support. Funding Information: Conflict of interest OB: research supports from Biophytis, IBSA, MEDA, Servier, SMB. PGC is supported in part by the UK NIHR Leeds Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. CC: lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Medtronic, Merck, Nestl{\'e}, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. TT: honorarium for lectures or advisory board from Abbvie, Amgen, Arrow, BMS, Chugai, Expanscience, Gilead, HAC-Pharma, LCA, Lilly, Medac, MSD, Pfizer, Thuasne, TEVA and UCB; research support from Amgen, Bone Therapeutics, Chugai, HAC-Pharma, MSD, Novartis, Pfizer, and UCB. JYR: consulting fees or paid advisory boards from IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Teva; lecture fees when speaking at the invitation of sponsor: IBSA-Genevrier, Mylan, CNIEL, Dairy Research Council, Teva; Grant support from industry (all through institution) from IBSA-Genevrier, Mylan, CNIEL, Radius Health. OB research supports from Biophytis, IBSA, MEDA, Servier, SMB. NAD, CB, JB, CC, MH, GHB, FJ, DP, WL, and RR have no conflict of interest relevant to the content of this study.",

year = "2019",

month = jan,

day = "25",

doi = "10.1007/s40520-018-1098-3",

language = "English",

volume = "31",

journal = "Aging Clinical and Experimental Research",

issn = "1594-0667",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

Hiligsmann, M, Pinto, D, Dennison, E, Al-Daghri, N, Beaudart, C, Branco, J, Bruyère, O, Conaghan, PG, Cooper, C, Herrero-Beaumont, G, Jiwa, F, Lems, W, Rizzoli, R, Thomas, T, Veronese, N & Reginster, JY 2019, 'Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies', Aging Clinical and Experimental Research, VOL. 31, Numéro 1. https://doi.org/10.1007/s40520-018-1098-3

TY - JOUR

T1 - Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies

AU - Hiligsmann, Mickael

AU - Pinto, Daniel

AU - Dennison, Elaine

AU - Al-Daghri, Nasser

AU - Beaudart, Charlotte

AU - Branco, Jaime

AU - Bruyère, Olivier

AU - Conaghan, Philip G.

AU - Cooper, Cyrus

AU - Herrero-Beaumont, Gabriel

AU - Jiwa, Famida

AU - Lems, Willem

AU - Rizzoli, Rene

AU - Thomas, Thierry

AU - Veronese, Nicola

AU - Reginster, Jean Yves

N1 - Funding Information: No funding was received for this study. The authors are grateful to the Prince Mutaib Chair for Biomarkers of Osteoporosis, King Saud University, Riyadh, Saudi Arabia, for its support. Funding Information: Conflict of interest OB: research supports from Biophytis, IBSA, MEDA, Servier, SMB. PGC is supported in part by the UK NIHR Leeds Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. CC: lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Medtronic, Merck, Nestlé, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. TT: honorarium for lectures or advisory board from Abbvie, Amgen, Arrow, BMS, Chugai, Expanscience, Gilead, HAC-Pharma, LCA, Lilly, Medac, MSD, Pfizer, Thuasne, TEVA and UCB; research support from Amgen, Bone Therapeutics, Chugai, HAC-Pharma, MSD, Novartis, Pfizer, and UCB. JYR: consulting fees or paid advisory boards from IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Teva; lecture fees when speaking at the invitation of sponsor: IBSA-Genevrier, Mylan, CNIEL, Dairy Research Council, Teva; Grant support from industry (all through institution) from IBSA-Genevrier, Mylan, CNIEL, Radius Health. OB research supports from Biophytis, IBSA, MEDA, Servier, SMB. NAD, CB, JB, CC, MH, GHB, FJ, DP, WL, and RR have no conflict of interest relevant to the content of this study.

PY - 2019/1/25

Y1 - 2019/1/25

UR - http://www.scopus.com/inward/record.url?scp=85059528385&partnerID=8YFLogxK

U2 - 10.1007/s40520-018-1098-3

DO - 10.1007/s40520-018-1098-3

M3 - Editorial

C2 - 30607878

AN - SCOPUS:85059528385

SN - 1594-0667

VL - 31

JO - Aging Clinical and Experimental Research

JF - Aging Clinical and Experimental Research

IS - 1

ER -